Yezan Munther Haddadin
CIK 1718004 · last filed 2026-06-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$80.7K
Companies
3
Total Filings
22
Lifetime Open-Market Net
$143.6K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 66,167 | $1.22 | $80.7K | $104.3K | 11 | 2026-06-03 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 30,000 | $0.03 | $900 | $39.3K | 10 | 2021-12-02 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | — | — | — | $0 | 1 | 2017-11-02 |
Recent Filings · Page 2 of 3
22 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-03-24 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2021-12-02 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +10,000 | $13.9K | EDGAR |
| 2021-10-07 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-04-20 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +10,000 | $18.2K | EDGAR |
| 2021-03-26 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-10-05 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-09-22 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Buy (P) | +10,000 | $7.2K | EDGAR |
| 2020-07-21 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-03-20 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-01-06 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.